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We have used recombinant vaccinia viruses expressing full-length or truncated gag or env genes of SIVmac239 to
investigate the requirements for assembly of SIV proteins. We observed that assembly of virus-like particles (VLPs) was
found to be 3- to 5-fold higher with full-length Env than with the truncated forms, or than VLPs containing only Gag proteins,
in primary monkey cells or various human cell lines. When cells expressing Env proteins in the absence of Gag were
examined by immunoelectron microscopy, clusters of Env protein and membrane vesicles containing Env proteins were
observed at cell surfaces. A low level of vesicles was released from cells expressing full-length Env, but about a 10-fold
higher level was released in cells expressing a truncated form of Env [Env733(t)] in which the cytoplasmic domain is only
17 amino acids in length. Another truncated protein, Env718(t), with a short cytoplasmic tail of 3 aa, was also incorporated
into VLPs at a 10-fold higher level than the full-length Env protein and was more efficiently released in vesicles. The mature
SU and TM proteins were predominantly incorporated into VLPs with full-length Env, but both cleaved and uncleaved
precursor proteins were present in VLPs with truncated Env as well as in Env and Env(t) vesicles. A more prominent layer
of spikes was seen by electron microscopy in VLPs with truncated Env than in VLPs containing full-length Env. These results
indicate that truncated Env proteins have the ability to self-associate on the cell surface and are assembled into a more
closely packed array than full-length Env, which could explain the preferential incorporation of Env proteins with short
cytoplasmic tails into virions. q 1996 Academic Press, Inc.
INTRODUCTION incorporation of envelope proteins into virions imposed
by mutations in the MA protein.
Assembly of SIV virions involves association of the In contrast to other retroviruses, the TM glycoproteins
envelope and core proteins in a manner similar to that of lentiviruses contain an unusually long cytoplasmic tail
of other retroviruses. The association may occur either of approximately 150 to 200 amino acids. The full-length
intracellularly or at the cell surface and correlates with TM protein of SIV is not required for productive infection
the site of virus budding from target cells (Gendelman et in most cell lines (Chakrabarti et al., 1989; Kodama et
al., 1989; Klatzmann et al., 1984). During maturation of al., 1989; Mulligan et al., 1992). Envelope proteins with
HIV-1, the site of expression of Env proteins can deter- a truncated cytoplasmic tail were found to be more fuso-
mine the site of release of Gag proteins in polarized genic (Ashorn et al., 1990; Mulligan et al., 1992; Ritter et
epithelial cells, and budding occurs preferentially from al., 1993) and the truncation had no effect on levels of
the basolateral side (Owens and Compans, 1989; Owens Env expression on the cell surface (Ritter et al., 1993).
et al., 1991). The interaction between the TM subunit of Further analysis of HIV and SIV Env truncation mutations
the Env protein and the MA subunit of the Gag protein showed that the cytoplasmic sequences affected fusion
is important for this process. Studies of Rous sarcoma activity but not transport to the cell surface (Owens et
virus using chemical crosslinking have shown that an al., 1994; Spies and Compans, 1994). This conclusion is
further supported by observations with HIV-1 Env pro-interaction between the TM and MA proteins occurs dur-
teins in which the cytoplasmic tails and membrane span-ing the budding process (Gebhardt et al., 1984). In addi-
ning domains were replaced by a C-terminal glycosyl–tion, HIV-1 envelope incorporation into virus was blocked
phosphatidylinositol attachment signal (Salzwedel et al.,by deletions and amino acid changes in the MA protein
1993). In these studies, the GPI anchor decreased syncy-(Dorfman et al., 1994; Yu et al., 1992). Recently, Freed and
tium formation but was sufficient for intracellular trans-Martin (1995) showed a specific functional interaction
port or incorporation into virions. Gabuzda et al. (1992)between the TM and MA proteins of HIV-1 by using site-
reported that deletions in the cytoplasmic tail of the HIV-directed mutagenesis. Env proteins with short cyto-
1 Env protein reduced the efficiency of virus entry butplasmic tails were found to overcome a block in the
did not affect the incorporation into virions. Moreover,
truncation of the cytoplasmic domain of the SIV envelope
glycoprotein increased Env incorporation into particles1 To whom reprint requests should be addressed.
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and expanded the viral host range (Johnston et al., 1993; (2380 bp) including the gag gene and a portion of the
overlapping pol gene was gel isolated and treated brieflyZingler and Littman, 1993). Thus, it seems that some
mechanism must exist for preferential incorporation of with Bal31 exonuclease to remove untranslated se-
quences 5* to the gag ATG initiation codon. After repairtruncated Env protein into virions.
In this study, we have used a vaccinia expression sys- with the Klenow fragment of DNA polymerase, the seg-
ments were blunt-end ligated into SalI-linearized andtem to investigate conditions for assembly of SIVmac239
virus-like particles (VLPs). Previous studies have shown Klenow-treated pGEM-11z. Among the resulting plasmid
clones with inserts in the appropriate orientation for T7that HIV-1 and SIV core proteins expressed from vaccinia
virus (VV) recombinants can be assembled into VLPs in expression, one was found by nucleotide sequence anal-
ysis to have a 2235-bp insert including 47 nucleotidesthe presence or absence of envelope proteins (Gheysen
et al., 1989; Haffar et al., 1990; Karacostas et al., 1989; upstream from the gag ATG initiation codon. A universal
translation terminator linker (GCTTAATTAATTAAGC,Shioda and Shibota, 1990; Smith et al., 1990; Owens et
al., 1991; Vzorov et al., 1991), providing an important ad- Pharmacia 27-4890) was inserted at the StuI site (located
in the overlapping region of gag and pol) to yield pT7-vantage for these studies. We have investigated the inter-
action between Gag and Env proteins, and release of 239Gag(t), or at the Xho site (located in the residual
pGEM polylinker at the 3* end of the insert) to yield pT7-SIVmac239 VLPs. We compared constructs with full-
length Env and with truncations in the cytoplasmic tail 239Gag-Pol(t). A T7 transient expression system was
used to confirm the expression of the Gag polyprotein,of the TM protein, as well as Gag constructs with or
without protease activity. and the presence of gag proteolytic products indicated
expression of functional SIV protease for pT7-239Gag-
Pol(t). A smaller Gag polyprotein was observed for pT7-MATERIALS AND METHODS
239Gag which is predicted to be truncated by 72 amino
Cells and viruses acids, with the C-terminal glycine residue replaced by
asparagine. No Gag proteolytic products were observedHEp2, HeLa, HeLa T4, TK0 143B, and Vero cells were
for this construct, indicating the absence of a functionalmaintained in Dulbecco’s minimal essential medium
SIV protease. An EcoRI to HindIII restriction fragment of(DMEM) supplemented with 10% newborn calf serum and
pT7-239Gag(t) and of pT7-239Gag-Pol(t) and linearizedadditionally supplemented with 0.29 mg/ml of L-gluta-
pSC11 plasmids were purified by electroelution, the endsmine and 0.01 M HEPES for roller bottles. Suspension
of the gag(t) or gag-pol(t) filled in with Klenow polymer-cell lines HUT 78, H9, Molt4, and primary rhesus periph-
ase, and the resulting fragments ligated into plasmideral blood mononuclear leukocytes (PBMC) were main-
pSC11 in the SmaI site. The resulting vaccinia recombi-tained in RPMI 1640 supplemented with 15% fetal bovine
nation plasmids were designated pSC11-239Gag(t) andserum, and additionally supplemented with 0.29 mg/ml
pSC11-239Gag-Pol(t).of L-glutamine and 0.01 M HEPES. Blood from rhesus
macaques was kindly provided by Dr. F. Novembre.
Construction of recombinant vaccinia virusesPBMC were isolated by the Pharmacia Biotech proce-
dure. Recombinant vaccinia viruses expressing full- TK0 143B cells were infected with wild-type vaccinia
length (VV-239env) and truncated (VV-239T) SIVmac239 virus (IHD-J strain) and then transfected with plasmid
envelope proteins were described by Ritter et al. (1993). pSC11-239Gag(t) or pSC11-239Gag-Pol(t), as described
For preparation of virus stocks, TK0 143B cells in roller previously (Mulligan et al., 1990). Recombinant vaccinia
bottles were infected by a low m.o.i. of each virus and viruses were obtained using a double selection proce-
incubated for 44 hr at 377, and then cells were harvested dure based on BUdR resistance and b-galactosidase ex-
and virus purified by pelleting on a 36% sucrose cushion pression (Chakrabarti et al., 1988). A control, VV-SC11
as described by Mackett et al. (1985). Virus titers were expressing b-galactosidase, has been described (Ow-
determined by plaque assay on TK0 143B cells. The cells ens and Compans, 1989). All recombinants were grown
were incubated for 30–48 hr at 377 and plaques visual- and titered in TK0 143B cells.
ized by staining with a solution of 0.1% crystal violet, 10%
formaldehyde in PBS, or a solution of 1% agar with 0.01% Construction of Env–Rev SIVmac239 plasmids for
neutral red. A b-galactosidase screening assay was also transient transfection
used (Chakrabarti et al., 1988).
An NheI to BglII restriction fragment of pSC11-239T
with a site-specific C to T mutation sequence (nucleotideConstruction of gag plasmid vectors
8803; Reiger and Desrosiers, 1990), which creates a ter-
mination codon after aa 733 of the envelope precursorA plasmid pSPSGP containing a NarI to SacI fragment
(including the entire gag and pol open reading frames and is otherwise isogenic (Ritter et al., 1993), was in-
serted into the NheI to BglII site of p239-RE containing revof the SIVmac239 proviral genome) was obtained from P.
Johnston. A KpnI to BstEII restriction fragment of pSPSGP and env genes for subcloning, and a plasmid designated
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p239-RE(t) was obtained. A BamHI restriction fragment in 12 fractions of 1 ml, and each fraction was analyzed
using Western blot, RIP, and electron microscopy. Frac-of p239-RE(t) was ligated to the plasmid vector pREP10
(Invitrogen) in a BamHI site. The resulting plasmid was tions 11, 10, and 9 were combined, dissolved in PBS,
and pelleted for 1 hr at 29k. A large amount of Gagdesignated pRE239-RE(t). Full-length env and rev genes
(BamHI) from p239-RE were ligated into the plasmid vec- and Env proteins was found in upper fractions whereas
vaccinia virus proteins were observed in lower fractionstor pREP7 (Invitrogen) in a BamHI site. The resulting plas-
mid was designated pRE239-RE. Expression of these 1–4 and also at the bottom of the gradient. Separation
of VLPs and vaccinia virus particles was also confirmedplasmids was evaluated in HEp2 cells by transfection
with Lipofectin (GIBCO BRL) following the transfection by electron microscopic examination of sucrose fractions
and silver staining of protein gels. The pellet was thenprotocol provided by the manufacturer.
analyzed by RIP or an additional step of purification was
Recombinant virus infection, radiolabeling, and used. The pellet was suspended in 100 ml PBS, loaded
quantitation on a 20–60% sucrose gradient, and centrifuged for 18 hr
at 24k in a SW41 rotor. The 12 fractions were collected,
Confluent monolayers of HEp2 cells were infected with
dissolved in PBS, pelleted by centrifugation for 1 hr at
VV-239gag or VV-239gag-pol and/or VV239env or VV-
29k in a SW41 rotor, and analyzed by RIP.
239env(t) recombinants at a multiplicity of infection of 10
Electron microscopyPFU per cell of each virus. At 10–17 hr postinfection, the
cells were starved in cysteine- and methionine-deficient HEp2 cells in 35-mm dishes were infected with 10
DMEM for 1 hr 15 min. For pulse-chase experiments, PFU per cell of each recombinant virus: VV-239gag-pol
/ VV239env(t), VV-239gag-pol / VV-239env, or VVgag-the cells were pulse-labeled for 15 min with 100 mCi
pol. At 25 hr postinfection, cells were fixed with 1% glutar-of [35S]cysteine/methionine per milliliter and chased for
aldehyde in PBS, postfixed with osmium tetroxide, andvarious periods with DMEM containing 10% newborn calf
stained with tannic acid (Allan et al., 1992). The samplesserum. For continuous radiolabeling with [35S]cysteine/
were dehydrated with a graded series of ethyl alcoholmethionine we used 65 mCi per milliliter. After 5 hr label-
and embedded in EMBED 812 (Electron Microscopy Sci-ing, 2% dialyzed serum was added. For RIP analysis, the
ences, Ft. Washington, PA). Thin sections were stainedcells were lysed in RIP buffer [0.15 M NaCl, 1% Nonidet-
with uranyl acetate and lead citrate and examined withP40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate
a Philips CM 10 electron microscope at 80 kV.(SDS), 20 mM EDTA] with 1 mM PMSF. The culture media
For immunogold labeling of cell surfaces, HEp2 cells(6–12 ml from T75 flasks, 2 ml from 35-mm dishes, or 4 ml
in 35-mm dishes were infected with 7.5 PFU per cell offrom 60-mm dishes) were collected, clarified, and used
VV-239env or VV-239env733(t). At 12 or 22 hr cells weredirectly or following purification of virus-like particles for
washed with 0.3 M HEPES, pH 7.55, and prelabel blockedRIP analysis. The samples were immunoprecipitated
by 0.2 M HEPES with 1% normal goat serum and 1% BSAovernight at 47 with SIV-specific antisera from an infected
for 45 min at 47. The cells were then washed with 0.3 Mrhesus (provided by P. Marx) and protein A–agarose.
HEPES, pH 7.55, and incubated with SIV-specific antiseraThe agarose beads were then washed thoroughly and
(diluted 1:5) for 45 min at 47. Following extensive washingthe proteins characterized by 10% SDS–PAGE (Laemmli,
in 0.3 M HEPES, pH 7.55, with 0.5% BSA to remove un-1970) followed by autoradiography. The amounts of pro-
bound antibody, cells were incubated with goat anti-mon-tein were quantitated by densitometer analysis (NIH-Im-
key IgG conjugated to colloidal gold (10-nm particles; EYage V 1.54) or by use of a Phosphor Imager 445S1.
Laboratories, Inc., San Mateo, CA) and diluted 1:5 for
45 min at 47. Cells were again washed extensively withPurification of virus-like particles
HEPES/BSA and fixed with 1% glutaraldehyde in PBS at
For purification of virus-like particles, we used linear 47. Cells were postfixed for 1 hr at 47 in osmium tetroxide
sucrose gradients (15 to 40% and 20 to 60%) in SW41 in PBS and prepared for electron microscopy as de-
polyallomer tubes. Sucrose solutions were prepared in scribed previously (Roth et al., 1983; Jones et al., 1985).
10 mM Tris–HCl, pH 7.4, 0.1 mM PMSF. For removal of To fix cells before labeling, cells were incubated in 0.22
the vaccinia virus and the cell debris from the samples, M HEPES with 0.5% paraformaldehyde and 0.02 M lysine
the culture medium was harvested and clarified by cen- for 5 min at room temperature and washed three times
trifugation at 3.5k for 20 min (HS-4 Sorvall). The superna- with 0.3 M HEPES and one time with 0.3 HEPES, 0.02 M
tant was pelleted by centrifugation at 3 hr, 26k in an glycine. Fixed cells were labeled at room temperature
SW41 tube or pelleted through a 20% sucrose cushion. and processed and examined as described above.
Such pellets contained SIV proteins but also vaccinia
RESULTSproteins and cell debris. To further separate the VLPs,
Expression and release of recombinant proteinsthe pellet was suspended in 100 ml of PBS, loaded on a
15–40% sucrose gradient, and then centrifuged for 50 We have investigated the assembly of VLPs using re-
combinant vaccinia viruses expressing full-length or trun-min at 12.9k in an SW41 tube. The gradient was collected
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FIG. 1. Schematic representation of recombinant Gag and Env products. The SIVmac239 Gag–Pol construct includes the protease coding region.
In the SIVmac239gag construct, a 3* deletion of 216 bp deletes the protease coding region of the overlapping pol gene as well as the P6 gene.
Representation of the Gag protein is from Henderson et al. (1990). SIVmac239 Env has a full-length 354-amino-acid transmembrane (TM) protein,
whereas the 239 Env(t) protein is truncated at the C-terminus by 146 amino acids as described by Ritter et al. (1993). Premature termination signals
in Gag proteins are marked by an arrow, and the end of the pol gene sequence is indicated by a zig-zag line. N-terminal myristoylation moiety is
indicated by Myr. Shaded boxes represent the hydrophobic membrane-spanning regions in Env constructs.
cated Gag and Env proteins of SIVmac239, which are the cells infected with the VVSC11 control, two vaccinia-
coded bands of approximately 55 and 60 kDa were pres-shown schematically in Fig. 1. VVgag-pol contains the
entire gag gene including the protease coding sequence, ent after a 2-hr chase period (Fig. 2, lanes 3 and 4) and
were also seen in samples infected with recombinantwhereas VVgag contains a C-terminal deletion of 72
amino acids in the gag gene and no protease coding viruses; they were not found in uninfected HEp2 cells.
These results indicate that the Gag, Gag-Pol, and Env(t)sequence. VVenv contains the full-length env gene and
VVenv(t) codes for a protein with a C-terminal truncation proteins are expressed and processed in a similar man-
ner in singly or doubly infected cells.of 146 amino acids in the cytoplasmic domain. VVenv
and VVenv(t) have been described previously (Ritter et To determine the distribution of SIV proteins in density
gradients, HEp2 cells were infected with VV239gag (Fig.al., 1993).
To compare the processing of the Gag proteins, HEp2 3A), VV239gag-pol (Fig. 3B), VV239env(t) (Fig. 3C), or
VV239env (Fig. 3D) or doubly infected with VV239env(t)cells were singly or doubly infected with vaccinia recom-
binants, radiolabeled with [35S]cysteine/methionine for / VV239gag-pol (Fig. 3E) or VV239env / VV239gag-pol
(Fig. 3F). For purification of VLPs, a rate zonal followedvarious time periods, and analyzed by immunoprecipita-
tion and SDS–PAGE (Fig. 2). After a 15-min pulse, one by an equilibrium zonal sucrose gradient was used as
described under Materials and Methods, and each frac-major protein of approximately 50 kDa was observed in
cells infected with VVgag-pol (Fig. 2, lane 5). After 2- or tion of the second gradient was analyzed by RIP. Com-
parison of the distribution of Gag and Gag–Pol proteins3-hr chase periods, additional proteins appeared with
estimated molecular weights of 41, 25, and 24 k, repre- showed that both proteins were found in a few fractions:
Gag proteins at 1.13–1.16 g/ml and Gag–Pol at 1.12–senting cleavage products of the Gag precursor (Fig. 2,
lanes 7 and 8). A 47-kDa band was observed as the 1.16 g/ml (Figs. 3A and 3B). The distribution of Gag and
Gag–Pol proteins between several fractions may indi-major product for cells infected with VVgag, indicating
that it represents the uncleaved Gag protein, and no cate the presence of a variety of VLPs with different mor-
phologies. VLPs generated by the truncated Gag (withoutprocessing of this protein was seen after chase periods
(Fig. 2, lanes 14–17). Expression and processing of env protease activity) have an empty core and uncleaved
Gag, and this may affect the physical characteristics ofand env(t) gene products were found to be essentially
the same as described previously (Ritter et al., 1993) with the particles.
In cells expressing only the truncated SIVmac239 enva major band of approximately 140 kDa representing the
uncleaved Env precursor (Fig. 2, lanes 9–17). In cells gene, we observed that a large amount of Env proteins
was released into the medium and pelleted through thedoubly infected with Gag constructs and VVenv(t), Env
proteins were cleaved and gp120 was detected after 2- 20% sucrose cushion. The Env proteins were primarily
found in fractions with a density of 1.11–1.14 g/ml (Fig.or 3-hr chase periods (Fig. 2, lanes 11, 12, 16, and 17). In
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FIG. 2. Pulse-chase analysis of SIV protein expression and processing. Analysis of immune precipitates are shown for VV-SC11 (lanes 1–4),
VV239gag-pol (lanes 5–8), VV239gag-pol / VV239env(t) (lanes 9–12), and VV239gag / VV239env(t) (lanes 14–17). Pellets of medium from the
cells infected by VV239gag-pol / VV239env(t) (lane 13) or VV239gag (lane 18) (isolation procedure for VLPs) are indicated. At 22 hr postinfection,
the cells were pulse labeled with [35S]cysteine/methionine (100 mCi/ml) for 15 min (P) and chased with unlabeled cysteine/methionine for 40 min
at 2 and 3 hr. SIV-specific proteins in the cell lysate and pellets of medium were detected by immunoprecipitation with a polyclonal SIV antiserum.
Numbered arrows indicate approximate locations of molecular weight standards (left) and recombinant proteins (right).
3C). There was a large amount of gp120, and an overex- with full-length Env was about 3-fold higher than with
Env(t) and 2-fold higher than with VVgag-pol in the ab-posed autoradiograph also showed gp41. In samples
from cells expressing full-length Env, we observed low sence of Env proteins (not shown).
The above experiments demonstrated that Env(t) withlevels of gp120 and gp160 in fractions with a density of
1.13 to 1.12 g/m after overexposure (Fig. 3D). These re- a truncation of 146 amino acids was incorporated very
efficiently into VLPs. To determine the ability of Env con-sults indicate that both truncated Env as well as full-
length Env are released into the culture media in the structs with cytoplasmic tails of different lengths to be
assembled into VLPs, two other truncated envelope con-form of structures which pellet through a 20% sucrose
cushion. The amount of released Env protein was about structs were compared (Spies and Compans, 1994). We
found that Env-718(t) with a 3-aa cytoplasmic tail was10-fold higher with the Env(t) protein.
Figure 3E shows the distribution of particles containing incorporated into VLPs at a 10-fold higher level than full-
length Env. However, with Env-826(t) with a 111-aa cyto-Gag and Env(t) proteins. The Gag proteins were again
found predominantly in fractions with a density of 1.13– plasmic tail, very low levels of VLPs were detected, sug-
gesting that this construct suppresses VLP release (not1.16 g/ml, and Env(t) was found in these as well as low-
density fractions. Comparison of Fig. 3E with Fig. 3C shown). Densitometer analysis indicated that the ratio of
Env to Gag proteins for VLPgag-pol / env is about 1:100,shows a shift in distribution of Env(t) proteins to higher
density fractions, providing evidence for association of for VLPgag-pol / env733(t) about 1:10, and for VLPgag-
pol / env718(t) about 1:10. Therefore, the 733(t) andGag and Env(t). With Gag–Pol and full-length Env (Fig.
3F) although the distribution of Gag was similar we ob- 718(t) Env proteins are both incorporated into particles
at 10-fold higher levels than full-length Env, despite theserved a 10-fold lower level of Env in fractions containing
Gag, and no Env was found in low-density fractions. finding that the highest yield of VLPs was found with the
full-length Env protein.Taken together, these data demonstrate major differ-
ences in the ability of the different Env constructs to To confirm that Env proteins were incorporated into
VLPs and were not merely cosedimenting with Gag pro-be assembled into VLPs. When the amount of Gag p24
recovered in VLPs was compared to the amount in cell teins in the gradient, we isolated particles from the cul-
ture medium and used a polyclonal SIV-specific antibodylysates, it was found that the yield of VLPs was higher
with the full-length Env protein. The recovery of VLPs for precipitation of intact VLPs resuspended in PBS or
AID VY 7977 / 6a19$$$$43 05-30-96 16:03:03 vira AP: Virology
27ASSEMBLY AND RELEASE OF SIV ENV PROTEINS
FIG. 3. Analysis of proteins released from cells infected by recombinant vaccinia viruses. HEp-2 cells were infected with VV239gag-pol (A),
VV239gag (B), VV239env (C), and VV239env-733(t) (D) or doubly infected with VV239gag-pol / VV239env (E), or VV239gag-pol / VV239env-733(t)
(F) with a m.o.i. of 10 for each virus and then radiolabeled for 24 hr with [35S]cysteine/methionine beginning at 12 hr postinfection. The culture
medium was collected and purified by 15–40 and 20–60% sucrose gradients as described under Materials and Methods, and each fraction of the
20–60% sucrose gradient was analyzed by RIP. The total amount of proteins present in the autoradiograph was quantitated by using densitometer
analysis (NIH-Image v. 1.54).
VLPs disrupted in complete RIPA lysis buffer. In the sam- addition, Env(t) (Fig. 4, lanes 11 and 12) and full-length
Env (Fig. 4, lanes 8 and 9) were both present in largerple that contained intact VLPs, this specific antibody only
had access to surface proteins. The anti-SIV antibody amounts in VLPs from cells expressing Gag than with
Gag–Pol (Fig. 4, lanes 2, 3, 4, and 6). Differences werewas found to precipitate the intact VLPs containing both
the Gag and the Env proteins (not shown). In contrast, also observed in the amounts of uncleaved precursor
proteins found in the VLP preparations. With full-lengththe antibody did not recognize intact VLPs produced by
cells which expressed only Gag proteins. This result pro- Env we observed that the mature SU and TM proteins
were predominantly incorporated into VLPs (Fig. 4, lanesvides evidence that full-length or truncated Env proteins
are incorporated into the envelopes of VLPs that contain 1–3 and 7–9), but with Env(t) the incorporation of un-
cleaved gp140 was also observed (Fig. 4, lanes 4–6 andGag proteins.
In contrast to the VLPs with full-length Env, we ob- 10–12). Densitometer analysis indicated that the ratio of
gp120 to gp160 for VLPgag / env was 12 to 1, and inserved that the level of Env(t) proteins in VLPs was higher
and Gag proteins were reduced, suggesting that Env(t) VLPgag-pol / env we did not detect any gp160. In con-
trast with VLPgag / env(t) or VLPgag-pol / env(t) themay suppress the release of Gag proteins (Fig. 4). In
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FIG. 4. Incorporation of Env proteins into VLP. HEp2 cells were infected with recombinant viruses at the indicated m.o.i. and radiolabeled for 22
hr at 12 hr postinfection, the culture medium was collected, and VLPs were isolated by a 15–40% sucrose gradient. The sucrose fractions 9, 10,
and 11 were combined and analyzed by RIP. VLPs are compared from cells infected with VV239gag-pol and VV239env (lanes 1–3), VV239gag-pol
and VV239env(t) (lanes 4–6), V V239gag and VV239env (lanes 7–9), and VV239gag and VV239env(t) (lanes 10–12). Cells were infected with equal
m.o.i. of Gag and Env (lanes 3, 6, 9, and 12), with an excess of Env over Gag: VV239gag-pol to VV239env, m.o.i. ratio 10 to 40 (lane 1), 10 to 30
(lane 2); VV239gag to VV239env, 30 to 40 (lane 7), 10 to 30 (lane 8); or with an excess of Gag over Env: VV239gag-pol to VV239env(t), m.o.i. ratio
30 to 10 (lane 4), 20 to 10 (lane 5); VV239gag to VV239env(t), 60 to 10 (lane 10), 30 to 10 (lane 11). We used different m.o.i. of Env-expressing
viruses in some samples with Gag (lane 7) vs Gag–Pol (lane 1) because Gag was more sensitive than Gag–Pol to inhibition by coexpression of
Env proteins. Numbered arrows indicate approximate locations of recombinant proteins (left and right).
gp120 to gp140 ratio was about 3 to 1. These results Characterization of released Env protein complexes
indicate that the incorporation of uncleaved precursor During HIV and SIV infection of mammalian cell lines,
proteins into VLPs occurs upon truncation of the cyto- Env proteins are constitutively secreted at high levels,
plasmic tail of the TM protein. predominantly as oligomers (Rhodes et al., 1994). How-
ever, we observed that Env(t) proteins can sediment
The morphology of the VLPs
through a sucrose cushion, indicating that they are re-
leased from cells in larger structures. To investigate theTo investigate the morphology of the VLPs, we used
electron microscopy (Fig. 5). A more prominent layer of nature of the Env-containing structures, we used treat-
ment with a nonionic detergent (NP-40) which can dis-spikes was identified on VLPs containing Env(t) (Fig. 5A)
than on VLPs containing full-length Env (Fig. 5B), and no solve lipid vesicles but does not usually dissociate oligo-
meric protein complexes. The culture medium from cellsspikes were observed on particles which contained only
the Gag protein (Fig. 5C). These results are consistent infected by VV239env(t) was collected, precleared by
low-speed centrifugation, and loaded on a 20% sucrosewith the observation that Env(t) was incorporated into
VLPs at higher levels than full-length Env. The sizes of layer which contained 0.5% NP-40. Under these condi-
tions we did not find any Env proteins in the pellet afterVLPs with the various constructs were similar and ranged
from 75 to 175 nm. centrifugation (Fig. 6, lanes 1–3), indicating that the Env(t)
FIG. 5. Thin sections of VLPs. Cells were infected, fixed, and embedded and sections stained with tannic acid to visualize envelope spikes. VLPs
are from cells with VV239gag-pol and VV239env(t) (A), VV239gag-pol and VV239env (B), and VV239gag-pol (C). Magnification:1140,000 (A);1162,000
(B, C).
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vesicles occurs at high levels only in the constructs with
extensive truncations of the cytoplasmic tail. Transfection
experiments showed the same difference in release be-
tween full-length Env and the 733t Env protein as found
with recombinant vaccinia viruses (Fig. 7, lanes 11–14).
The results also show that gp120 as well as precursors
(gp160 or gp140) are incorporated in vesicles with full-
length (Fig. 7, lane 3) or with truncated Env (Fig. 7, lanes
7 and 9).
Distribution of Env proteins on cell surfaces
FIG. 6. Detergent treatment of Env-containing vesicles. HEp2 cells To further examine the distribution of full-length or trun-
were radiolabeled for 22 hr at 12 hr postinfection and at 48 hr post-
cated Env on cell surfaces, we examined the surfacestransfection. The culture medium was collected, 14 was used for immu-
of HEp2 cells by immunoelectron microscopy. At 12 hrnoprecipitation, and 34 was purified through a 20% sucrose cushion with
postinfection cells were labeled with monkey anti-SIV(/) or without (0) 0.5% NP-40. Pellets were diluted in lysis buffer and
analyzed by RIP. Samples are compared from total media (T), pellets antibodies, followed by goat anti-monkey IgG conjugated
(sucrose cushion) from cells infected with VV239env(t) (lanes 1–3), and to colloidal gold. We observed numerous patches of gold
cells transfected with pRE239-RE(t) (lanes 4–6). label on cell surfaces in cells expressing Env(t), or full-
length Env (Figs. 8A and 8C) and vesicular structures
labeled with gold particles in cells expressing Env(t) (Fig.
proteins are released from cells in the form of lipid-con- 8B). At 22 hr postinfection the number of vesicles in-
taining membrane vesicles. creased and some were also seen with full-length Env
To determine whether Env(t) is also released in vesi- (data not shown). When cells were fixed prior to immuno-
cles in the absence of vaccinia virus infection, we used gold labeling, similar structures were seen on cell sur-
DNA plasmids expressing Env(t) (pRE239-RE(t)) or full- faces, indicating that the finding of Env proteins in clus-
length Env (pRE239-RE) under control of the RSV pro- ters does not depend on redistribution by antibody during
moter. HEp2 cells were transfected by pRE239-RE(t) or labeling. These results support the conclusion that the
pRE239-RE with Lipofectin and after 46 hr cells were truncated Env(t) protein forms clusters on cell surfaces
labeled overnight with [35S]cysteine–methionine. The and is preferentially released from cells in vesicles.
culture medium was collected, clarified by low-speed
centrifugation, and then pelleted through a 20% sucrose DISCUSSION
cushion with or without NP-40. We observed pelleted
Env proteins in samples from cells transfected by We have investigated the assembly of SIV VLPs by
expression of gag genes with and without protease activ-pRE239-RE(t), and only in the samples without NP-40
(Fig. 6, lanes 4–6). This result is consistent with the data ity, as well as constructs with full-length and truncated
Env genes. We have obtained several lines of evidenceobtained for vaccinia vectors and indicates that Env(t)
proteins are released from cells in lipid-containing vesi- that full-length as well as truncated Env proteins are
incorporated into VLPs: (1) anti-SIV antibody interactedcles with either vaccinia expression or DNA transfection
of the truncated env gene. with intact particles and recognized VLPs which con-
tained Gag and Env proteins, but did not recognize VLPsTo determine how other truncations of the cytoplasmic
tail affect the release of Env proteins, we compared addi- without Env proteins; (2) electron microscopy showed
that particles with Env(t) contained a more prominenttional constructs with different truncations in the cyto-
plasmic tail (Spies and Compans, 1994). The amount of layer of spikes than particles with full-length Env; (3) a
shift in density of the Env(t) protein was observed inEnv (gp120) released into the media was approximately
the same with full-length Env and Env(t) as observed sucrose gradients upon coexpression of Gag proteins.
We found that the amount of VLPs released was signifi-previously by Ritter et al. (1993) (Table 1). Two other
constructs, SIVmac239-826t and SIVmac239-718t, cantly higher with processed vs unprocessed Gag pro-
teins, as reported for HIV-1 (Hu et al., 1990). Surprisingly,showed levels of gp120 secretion of 7.1 and 26.6%, re-
spectively, of the level seen with full-length Env. How- we observed the release of high levels of truncated Env
protein in a particulate form, even in the absence of Gagever, when we analyzed the release of Env proteins in
lipid vesicles (Fig. 7, lanes 4 and 8) low levels of Env proteins. These structures have a low density and are
sensitive to detergent, indicating that they representproteins were released from cells expressing SIVmac-
239env and SIVmac239-826t proteins (Fig. 7, lanes 3 and plasma membrane-derived vesicles. Immunogold label-
ing also showed such structures at cell surfaces by elec-5), and 10-fold higher levels were released with either
the 733t or the 718t proteins (Fig. 7, lanes 7 and 9). This tron microscopy. Comparison of four different env con-
structs showed that vesicles containing full-length Envresult indicates that incorporation of Env proteins into
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TABLE 1
Quantitation of the Release of Env Proteinsa
Recombinant vaccinia viruses SIVmac239 Plasmids with SIVmac239 gene
% of releaseb Env 826T 733T 718T Env 733T
Culture medium 17.3 7.1 18.5 26.6 5.3 8
Vesicles 0.05 0.03 0.72 0.5 0.19 1.84
a Cells were infected with vaccinia SIV239env recombinants or transfected by plasmids with SIV239env under RSV promoter.
b The total level of Env proteins in cell lysates was similar in each sample and was used as 100%.
or the SIVmac239-826T Env protein were released at results would tend to exclude the possibility that random
low levels, whereas both the SIVmac239-718T and the incorporation is responsible for the enhanced release of
SIVmac239-733T Env proteins were released with high Env(t) into vesicles. One of the functions of the cyto-
efficiency. Thus, assembly into vesicles occurs efficiently plasmic tail of the TM protein may be to stabilize anchor-
with molecules having an extensive truncation of the cy- age of Env proteins to underlying cytoplasmic structures,
toplasmic tail. The possible mechanisms by which these whereas Env(t) may not be anchored to such structures
Env proteins are released from cells include incorpora- and therefore can be released from cells in membrane
tion into plasma membrane vesicles that are constitu- vesicles. Our studies with immunogold labeling revealed
tively shed into the medium, preferential localization of clusters of Env proteins on cell surfaces, indicating an
Env(t) proteins in regions of the cell membrane involved ability of the proteins to self-associate. These results
in export, or self-assembly of Env(t) into low-density com- may be similar to observations of Rolls et al. (1994) with
plexes (Jones et al., 1990). In previous studies of full- vesicular stomatitis virus (VSV), who reported that ex-
length and truncated SIV Env proteins, the amount of pression of the VSV glycoprotein resulted in release of
soluble SU protein secreted into culture media and sur- membrane vesicles containing this protein.
face expression levels were not significantly different We observed with both full-length and truncated Env
(Ritter et al., 1993; Spies and Compans, 1994). These proteins that higher m.o.i. can increase incorporation into
VLPs, but for each envelope protein there appeared to
be an upper limit, and a 10-fold higher level of incorpora-
tion of Env(t) compared to Env was consistently observed.
More efficient incorporation of truncated Env proteins
into VLPs is consistent with previous reports (Zingler and
Littman, 1993; Johnston et al., 1993). Layne et al. (1992)
estimated that the ratio between Env and Gag for HIV-1
HXB3 particles was 1:120. Factors that may affect this
ratio include specific interaction between proteins during
assembly, features of the protein structure which could
affect the density of the proteins on the cell membrane
and particle surfaces, and the stability of the Env associa-
tion after release and during particle purification. Studies
with Rous sarcoma virus have provided evidence for an
interaction between the MA and TM proteins (Gebhardt
et al., 1984). Studies with HIV-1 also showed that muta-
tions in the cytoplasmic domain of the TM protein can
FIG. 7. Analysis of release of Env proteins in the medium. HEp2 impair the incorporation of the Env protein (Yu et al.,
cells were radiolabeled for 22 hr at 12 hr postinfection or at 48 hr 1993) and have provided evidence for a specific func-
posttransfection. The culture medium was collected and 14 was directly tional interaction between the HIV-1 matrix and the gp41
used for immunoprecipitation and 34 was used for isolation of vesicles
cytoplasmic tail (Yu et al., 1992; Freed and Martin, 1995).by a 15–40% sucrose gradient. The sucrose fractions 9, 10, and 11
But why is Env(t) of SIVmac239 incorporated more effi-were combined and analyzed by RIP. Samples of total media (T) and
vesicles (V) are compared from cells infected with VVSC11, VV239env, ciently in VLPs than full-length Env? Yang et al. (1995)
VV239env-826(t), VV239env-733(t) or VV239env-718(t), or cells showed that the HIV and SIV transmembrane protein
transfected with pREP10, pRE239-RE, or pRE239-RE(t). The total amount is palmitoylated, and this modification may affect Envof proteins present in the autoradiograph was quantified by using a
interaction with the viral membrane. Env(t) proteins whichPhosphor Imager (Table 1). Approximate locations of recombinant pro-
teins (left and right) are indicated. have a deletion of this region appear to be assembled
AID VY 7977 / 6a19$$$$43 05-30-96 16:03:03 vira AP: Virology
31ASSEMBLY AND RELEASE OF SIV ENV PROTEINS
FIG. 8. Surface expression of Env proteins. HEp2 cells were grown on 35-mm dishes and infected with either VV239env or VV239env-733(t). At
12 hr postinfection, cells were incubated with anti-SIV rhesus antisera, followed by a colloidal gold conjugate and fixed and embedded for electron
microscopy as described under Materials and Methods. (A, B) Cells infected with VV239env-733(t). (C) Cells infected with VV239env. Magnification:
152,000 (A, C); 150,000 (B).
into a more closely packed array, and this probably in- cleaved or uncleaved proteins irrespective of the Env
construct.creases the efficiency of incorporation. The finding that
After arrival of the plasma membrane, Env proteinsVLPs with Env(t) have more visible spikes also indicates
may self-associate and may be released from cells inthat Env(t) is more closely packed in these VLPs, indicat-
membrane vesicles or may be incorporated into buddinging that the truncated Env proteins have structural fea-
virus particles. We suggest that the truncated Env pro-tures which provide for optimal packaging into virus parti-
teins have the ability to associate into a more closelycles.
packed array because of their more compact cytoplasmicIt has been reported that uncleaved HIV-1 glycopro-
domain. This close packing may be responsible for bothteins are not efficiently incorporated into virus particles
the enhanced release of Env(t) proteins in vesicles asand that cleavage is required for incorporation of Env
well as the more efficient incorporation of such proteinsproteins (Dubay et al., 1995). In the vaccinia expression
into virus particles.system we also observed that the cleaved proteins are
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